Donald Fong, MD
Enriched profileChief of Ophthalmology, Kaiser Permanente Baldwin Park Medical Center; Director, Kaiser Permanente Southern California Eye Monitoring Center · Kaiser Permanente Baldwin Park Medical Center
Donald Fong is Chief of Ophthalmology, Kaiser Permanente Baldwin Park Medical Center; Director, Kaiser Permanente Southern California Eye Monitoring Center at Kaiser Permanente Baldwin Park Medical Center. OpenAlex indexes 118 publications with 7,052 citations (h-index 37); ClinicalTrials.gov lists 1 registered study with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Ophthalmology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Donald S. Fong, MD, is Chief of Ophthalmology, Kaiser Permanente Baldwin Park Medical Center. The public record shows 118 publications with 7,052 citations (h-index 37), centered on Diabetic Retinopathy / DME. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 2 companies, 1 NIH-funded awards (1995–2000).
- Most recent indexed publication: 2022 · International journal of retina and vitreous
- Top research focus: Diabetic Retinopathy / DME
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 2 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 1 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- Chair
FDA Advisory Committee on Ophthalmic Drugs
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →journal.gzzoc.com ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
- A Pilot Study of Laser Photocoagulation for Diabetic Macular Edema
Sponsor: Jaeb Center for Health Research
Industry payments
Updated 27 Aug 2026
2 companies reported payments to CMS in program years 2021–2024. These are public disclosures, not judgments. The latest:
- BioCryst Pharmaceuticals, Inc.Program year20243 payments$12,270openpaymentsdata.cms.gov ↗
- Allergan, Inc.Program year20212 payments$146,710openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
88.6%Prostaglandin Analog37.9%Latanoprost100%Part D≥14 patientsCorticosteroid22.9%Prednisolone Acetate100%Part D≥19 patientsMetabolism & gastrointestinal
11.4%Anticholinergic11.4%Atropine Sulfate100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
1 NIH research award on record, funded 1995–2000 per NIH RePORTER. The latest:
- ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITION IN DIABETIC RETINOPATHY
Charles R. Drew University of Med &sci
FY2000$32,581P20RR011145 - ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITION IN DIABETIC RETINOPATHY
Charles R. Drew University of Med &sci
FY1999P20RR011145 - ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITION IN DIABETIC RETINOPATHY
Charles R. Drew University of Med &sci
FY1998P20RR011145
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- C1q and the classical complement cascade in geographic atrophy secondary to age-related macular degeneration.
International journal of retina and vitreous
Review2022
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
healthy.kaiserpermanente.org/southern-california/physicians/donald-fong-1570693
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthy.kaiserpermanente.org ↗ - Other
asrs.org/find-a-specialist/profile/11705/Donald-S-Fong
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗ - X / Twitter
x.com/BioCrystPharma/status/1831651732738204044
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
University of Texas Health Science Center at San Antonio
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗ - MPH
Harvard T.H. Chan School of Public Health
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗ - Ophthalmology residency and vitreoretinal/diabetic-eye fellowship
Harvard Medical School / Massachusetts Eye and Ear Infirmary; additional fellowships at Joslin Diabetes Center and the National Eye Institute (NIH)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗
Editorial & leadership roles
journal and society appointments- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →journal.gzzoc.com ↗
- Member
American Society of Retina Specialists (ASRS)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗ - Member
American Academy of Ophthalmology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →superdoctors.com ↗
- Life Achievement Honor Award
American Academy of Ophthalmology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aao.org ↗ - Innovation Award
National Business Coalition on Health
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
Secondary affiliations
appointments beyond the home institution- Clinical Professor of Ophthalmology
UCLA David Geffen School of Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →journal.gzzoc.com ↗
Media & interviews
press, podcasts and appearances- Quoted in Kaiser Permanente Southern California Department of Research & Evaluation feature
"Diabetic eye damage reflects future cardiovascular risks"
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kp-scalresearch.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Lindsay Reder, MD
Kaiser Permanente Baldwin Park Medical Center
Stephan Chiu, MD
Kaiser Permanente Baldwin Park Medical Center
George Yuen, MD
Kaiser Permanente Baldwin Park Medical Center